Treat-and-extend intravitreal bevacizumab for branch retinal vein occlusion
BACKGROUND AND OBJECTIVE: To determine the effectiveness and direct medical costs of treat-and-extend (TAE) intravitreal bevacizumab (IVB) for the treatment of branch retinal vein occlusion (BRVO) - associated macular edema (ME). PATIENTS AND METHODS: Retrospective chart review of 52 consecutive pat...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Slack Incorporated
2014
|